Send feedback

ESPN p.Pro684=

c.2052G>A · rs375162948 · VCV1254602

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
very rare (popmax 0.0088%, sas)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
REVEL0.02moderately benign-leaning
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -1.3GERP -3
Overall
CADD6.497PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0088% South Asian · 8/90,922 alleles
Filtering AF 0.00437% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00313%
Overall 0.00316% 51/1,612,258 alleles · very rare
Ancestry group Frequency 1 in
South Asiangrpmax 0.0088% 11,365
African / African-American 0.00801% 12,490
Remaining individualsnot grpmax-eligible 0.00321% 31,194
European (non-Finnish) 0.00288% 34,698
East Asian 0.00223% 44,880

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ESPN
Protein
p.Pro684=
Coding
c.2052G>A
MANE Select
NM_031475
dbSNP
rs375162948
Type
single nucleotide variant
Location
chr1:6451739 (GRCh38)
Gene constraint
LOEUF 1.307 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 68.76
Residue 684
the 'disordered' region
Full ESPN gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/espn-p-pro684 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown